Lanthanum carbonate: a guide to its use as a phosphate-binding agent in patients with chronic kidney disease

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.26, Iss.8, 2010-08, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lanthanum Carbonate: A Review of its Use in Lowering Serum Phosphate in Patients with End-Stage Renal Disease

By Curran Monique P. Robinson Dean M.

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2329-2349

Adis International

Access to resources Recommend Favorite

Optimal use of phosphate binders in chronic kidney disease

By Sonikian Makrouhi Papachristou Evangelos Goumenos Dimitrios S

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2521-2532

Informa Healthcare

Access to resources Recommend Favorite

Methoxy polyethylene glycol-epoetin beta: a guide to its use in anaemia associated with chronic kidney disease

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 24, Iss. 11, 2008-11 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Lanthanum Carbonate - A New Phosphate Binding Drug in Advanced Renal Failure

Current Medicinal Chemistry, Vol. 25, Iss. 1, 2018-01 ,pp. : 113-117

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Enoxaparin in Patients with Chronic Kidney Disease: Safety Considerations

By Brophy Donald F. Sica Domenic A.

Drug Safety, Vol. 30, Iss. 11, 2007-01 ,pp. : 991-994

Adis International

Access to resources Recommend Favorite